510(k) · Cleared
Recalled · Class II · 2016Laserex Duo Family of Dual Wavelength Ophthalmic Lasers Including Models Integre Duo LP1RG-S, LP1RG-D
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Ellex Medical Pty, Ltd. · GEX Powered Laser Surgical Instrument
Cleared on Mar 16, 2006 after a 164-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 5 later devices descend from it. It has been recalled 2 times.
- Decided
- Mar 16, 2006
- Review
- 164 days
- Class
- Class II
- Product code
- GEX
- Recalls
- 2
- Predicates
- 0
5 later devices descend from it, 3 citing it directly.
- This deviceK052777 Laserex Duo Family of Dual Wavelength Ophthalmic Lasers Including…Ellex Medical Pty, Ltd. · 2006
- Descendant · cites it directly · 2 of its ownK103547 Lightlas Multi-Wavelength Medical Laser SystemLightmed Corp. · 2011
- Descendant · 2 generations on · 0 of its ownK152688 LightLas Multi-Wavelength Medical Laser SystemLightmed Corporation · 2016
- Descendant · 2 generations on · 0 of its ownK124043 Lightlas Family of Multi-Wavelength Medical Laser SystemLightmed Corp. · 2013
- Descendant · cites it directly · 0 of its ownK081565 Integre Pro, Model L2RYEllex Medical Pty, Ltd. · 2008 · Recalled
- Descendant · cites it directly · 0 of its ownK080423 Integre, Model LP581Ellex Medical Pty, Ltd. · 2008
Most influential descendants
Showing 5 of 5 · See all- K103547Lightlas Multi-Wavelength Medical Laser SystemLightmed Corp. · 2011 · cites it directly2descendants
- K152688LightLas Multi-Wavelength Medical Laser SystemLightmed Corporation · 2016 · 2 generations on0descendants
- K124043Lightlas Family of Multi-Wavelength Medical Laser SystemLightmed Corp. · 2013 · 2 generations on0descendants
- K081565Integre Pro, Model L2RYEllex Medical Pty, Ltd. · 2008 · cites it directly0descendants
- K080423Integre, Model LP581Ellex Medical Pty, Ltd. · 2008 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K052777 | Laserex Duo Family of Dual Wavelength Ophthalmic Lasers Including Models… | Ellex Medical Pty, Ltd. | 2006 | — |
| +1 | K103547 | Lightlas Multi-Wavelength Medical Laser System | Lightmed Corp. | 2011 | — |
| +2 | K152688 | LightLas Multi-Wavelength Medical Laser System | Lightmed Corporation | 2016 | — |
| +2 | K124043 | Lightlas Family of Multi-Wavelength Medical Laser System | Lightmed Corp. | 2013 | — |
| +1 | K081565 | Integre Pro, Model L2RY | Ellex Medical Pty, Ltd. | 2008 | 1 |
| +1 | K080423 | Integre, Model LP581 | Ellex Medical Pty, Ltd. | 2008 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2008 | 2 | 0 |
| 2011 | 1 | 0 |
| 2013 | 1 | 0 |
| 2016 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GEX device
- #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against?
FDA’s file for it is a 510(k) statement, which names no predicate.
What descends from it? (5)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Feb 1, 2016 | Class II | Z-1270-2016 | Device Design | The Firm discovered that there is a design error which is traceable back to 2012 when a design change on the safety filter optic adaptor was implemented. |
| Jun 13, 2007 | Not classified | Z-0287-2008 | Device Design | Electric Shock from Power Supply: The power supply has a defect which can cause an electrical shock to user. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K103547 (Lightmed Corp., 2011) has gone furthest, with 2 descendants of its own.
How does its category compare?
All GEX devicesGEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GEX
83in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GEX
90in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GEX
3in 2024
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · GEX
2,720in 2025
MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 73 | 79 | 9 | 342 |
| 2008 | 107 | 86 | 2 | 232 |
| 2009 | 69 | 100 | 0 | 209 |
| 2010 | 50 | 96 | 4 | 1,711 |
| 2011 | 41 | 83 | 18 | 3,024 |
| 2012 | 45 | 118 | 5 | 2,000 |
| 2013 | 46 | 144 | 3 | 2,236 |
| 2014 | 61 | 147 | 6 | 2,036 |
| 2015 | 47 | 112 | 0 | 2,099 |
| 2016 | 51 | 114 | 1 | 2,585 |
| 2017 | 67 | 90 | 5 (1) | 2,977 |
| 2018 | 51 | 78 | 5 | 3,525 |
| 2019 | 41 | 88 | 6 | 2,709 |
| 2020 | 52 | 90 | 1 | 2,183 |
| 2021 | 53 | 123 | 0 | 3,465 |
| 2022 | 60 | 152 | 0 | 2,288 |
| 2023 | 52 | 87 | 6 | 2,337 |
| 2024 | 82 | 90 | 3 | 2,187 |
| 2025 | 83 | 90 | 0 | 2,720 |
| 2026 | 57 | 90 | 2 | — |
What is it indicated for?
The Laserex Duo family of dual wavelength ophthalmic lasers are intended for use in the treatment of ocular pathology. The Laserex Duo is indicated for use in photocoagulation of both anterior and posterior segments of the eye including: - Retinal photocoagulation and pan retinal photocoagulation of vascular and structural abnormalities of the retina and choroid including: - proliferative and nonproliferative diabetic retinopathy; - choroidal…
Read the full statement (97 words)
The Laserex Duo family of dual wavelength ophthalmic lasers are intended for use in the treatment of ocular pathology.
The Laserex Duo is indicated for use in photocoagulation of both anterior and posterior segments of the eye including:
- Retinal photocoagulation and pan retinal photocoagulation of vascular and structural abnormalities of the retina and choroid including:
- proliferative and nonproliferative diabetic retinopathy;
- choroidal neovascularization;
- branch retinal vein occlusion;
- age-related macular degeneration;
- retinal tears and detachments;
- retinopathy of prematurity;
* Iridotomy, iridectomy, suturelysis and trabeculoplasty in angle closure glaucoma and open angle glaucoma
Indications for use as stated in the FDA 510(k) statement.
https://510kreport.com/device/K052777 · printed Nov 6, 2026
Cite this page
510(k) Report. “K052777: Laserex Duo Family of Dual Wavelength Ophthalmic Lasers Including Models Integre Duo LP1RG-S, LP1RG-D.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K052777
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026